ArticleNeurology. Clinical practice2015
Alzheimer disease prevention: New optimism.
Article in Neurology. Clinical practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 7 citations in OpenAlex.
- White matter dementia then… and now.Frontiers in neurology · 2022Review
- Encouraging trends toward reduced risk of Alzheimer disease: What's good for the heart is good for the brain.Neurology. Clinical practice · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer disease (AD) poses a major threat to medicine and society, but recent epidemiologic data indicate declining incidence of the disease. This development may be due to prevention of many cases by attention to modifiable risk factors. Meanwhile, all treatment efforts using drugs targeting amyloid have failed. In contrast to the assumption of recent decades that sporadic AD is primarily a genetic disease in which neuritic plaques and neurofibrillary tangles are mainly responsible for clinical features, it is now time for a more nuanced approach that considers the role of environmental factors preceding dementia onset and the appearance of aggregated proteins. This view of AD has important implications for medical care and health policy, and for counseling individuals to adopt lifestyle strategies that can be effective for prevention.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.